Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons
Javier Oesterheld, William Ferguson, Jacqueline M. Kraveka, Genevieve Bergendahl, Thomas Clinch, Elizabeth Lorenzi, Don Berry, Randal K. Wada, Michael S. Isakoff, Don E. Eslin, Valerie I. Brown, William Roberts, Peter Zage, Virginia L. Harrod, Deanna S. Mitchell, Derek Hanson, Giselle L. Saulnier Sholler
Dive into the research topics of 'Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons'. Together they form a unique fingerprint.